Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to close the screening gap for black and hispanic patients

NCT ID NCT06401174

Knowledge-focused Sponsor: Medstar Health Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether patient navigators and reminder systems can help more Black and Hispanic adults aged 45-75 get screened for colorectal cancer. About 1,800 people from 15 clinics will take part. The goal is to find better ways to make sure everyone gets the screening they need.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 45-75 * Due for colorectal cancer screening * Identify as Black or Hispanic/Latino * Attend primary care visit at one of the 15 selected clinics within the step time -period Exclusion Criteria: \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal cancer screening

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    15 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Charlotte Hall

    Charlotte Hall, Maryland, 20622, United States

  • Family Medicine

    Gaithersburg, Maryland, 20878, United States

  • Family Medicine

    Olney, Maryland, 20832, United States

  • Family Medicine Fort Lincoln

    Washington D.C., District of Columbia, 20722, United States

  • Family Medicine Spring Valley

    Washington D.C., District of Columbia, 20016, United States

  • Franklin Square

    Baltimore, Maryland, 21237, United States

  • Harbor Hospital Primary Care Federal Hill

    Baltimore, Maryland, 21230, United States

  • Honeygo

    Baltimore, Maryland, 21128, United States

  • Internal Medicine Clinton

    Clinton, Maryland, 20735, United States

  • Internal Medicine Hyattsville

    Hyattsville, Maryland, 20782, United States

  • Internal Medicine Wisconsin Avenue

    Washington D.C., District of Columbia, 20007, United States

  • MedStar Adult Medicine at Union Memorial

    Baltimore, Maryland, 21218, United States

  • Olney Prof Park

    Olney, Maryland, 20832, United States

  • Primary Care Lafayette

    Washington D.C., District of Columbia, 20036, United States

  • Primary Care at Franklin Square

    Baltimore, Maryland, 21237, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.